Cue Biopharma (CUE) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with formal roles assigned for presiding officer, inspector of election, and secretary.

• Meeting conducted virtually, with procedures for participation and voting explained.

• Forward-looking statements disclaimer provided, referencing risk factors in recent SEC filings.

Specific resolutions to be voted on

• Approval of issuance of common stock upon exercise of warrants related to a May 2026 licensing transaction and private placement.

• Approval of the 2026 Stock Incentive Plan.

• Approval to adjourn the meeting if necessary to solicit further proxies for the above proposals.

Corporate governance

• Record date for stockholders set as May 8, 2026, with notice and affidavit filed.

• Quorum confirmed by inspector of election, allowing business to proceed.

• Voting rules and procedures outlined, including proxy voting and board recommendations.